Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1.

Intranasal or intramuscular treatment of calves with recombinant bovine alpha 1 interferon before challenge with bovine herpesvirus type 1 and Pasteurella haemolytica reduced clinical signs, number of sick days, lung lesions, and weight loss. The effective dose was determined to be relatively broad...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Babiuk, L A, Lawman, M J, Gifford, G A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174827/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3038008/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.5.752
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!